| Literature DB >> 33169295 |
Francesco Rizzetto1, Francesca Calderoni2, Cristina De Mattia2, Arianna Defeudis3,4, Valentina Giannini3,4, Simone Mazzetti3,4, Lorenzo Vassallo5, Silvia Ghezzi6, Andrea Sartore-Bianchi6,7, Silvia Marsoni8, Salvatore Siena6,7, Daniele Regge3,4, Alberto Torresin2,9, Angelo Vanzulli10,11.
Abstract
BACKGROUND: Radiomics is expected to improve the management of metastatic colorectal cancer (CRC). We aimed at evaluating the impact of liver lesion contouring as a source of variability on radiomic features (RFs).Entities:
Keywords: Colorectal neoplasms; Image processing (computer-assisted); Liver neoplasms; Radiomics; Tomography (x-ray; computed)
Mesh:
Substances:
Year: 2020 PMID: 33169295 PMCID: PMC7652946 DOI: 10.1186/s41747-020-00189-8
Source DB: PubMed Journal: Eur Radiol Exp ISSN: 2509-9280
Fig. 1For each metastasis, the whole lesion volume and the largest axial cross-section were segmented by two readers. a Purple line (reader 1) versus yellow line (reader 2) contouring. The largest two-dimensional (2D) region of interest (ROI) of the main lesion was confronted with two circular ROIs, one inside the metastasis and one outside it. b Purple line (reader 1) 2D versus yellow line (smallest circular ROI inclusive of the whole lesion) versus azure line (largest circular ROI completely inside the lesion)
Demographical data and number of analysed metastases for each patient enrolled in the study
| Patient | Age at CT (years) | Sex | Primary cancer site | Number of analysed metastases | Lines of treatment | Chemotherapy regimens |
|---|---|---|---|---|---|---|
| 1 | 77 | F | Rectum | 1 | 2 | FOLFOX + bevacizumab FOLFIRI + cetuximab |
| 2 | 66 | M | Colon (left) | 5 | 2 | FOLFOX FOLFIRI + cetuximab |
| 3 | 62 | M | Colon (left) | 3 | 4 | FOLFIRI + cetuximab Regorafenib Trifluridine/tipiracil Capecitabine |
| 4 | 59 | M | Colon (left) | 1 | 2 | FOLFOX FOLFIRI + cetuximab |
| 5 | 56 | M | Rectum | 1 | 2 | FOLFIRI + cetuximab Not available |
| 6 | 40 | M | Colon (left) | 2 | 2 | FOLFOX + panitumumab FOLFIR I + bevacizumab |
| 7 | 61 | M | Colon (left) | 4 | 2 | FOLFOX + panitumumab FOLFIRI + aflibercept |
| 8 | 56 | M | Colon (right) | 6 | 2 | FOLFOX + panitumumab FOLFIRI + aflibercept |
| 9 | 47 | M | Colon (left) | 5 | 2 | FOLFOX + cetuximab FOLFIRI + bevacizumab |
| 10 | 32 | M | Colon (left) | 7 | 3 | FOLFOXIRI + bevacizumab FOLFIRI + aflibercept Panitumumab |
| 11 | 66 | M | Colon (left) | 6 | 2 | XELIRI FOLFOX + bevacizumab |
| 12 | 63 | F | Colon (left) | 8 | 2 | FOLFOX + panitumumab FOLFIRI + bevacizumab |
| 13 | 61 | F | Colon (left) | 1 | 2 | XELOX + bevacizumab FOLFIRI + cetuximab |
| 14 | 52 | M | Rectum | 2 | 2 | FOLFOX FOLFOX + bevacizumab |
| 15 | 41 | M | Colon (left) | 5 | 1 | FOLFOX + panitumumab |
| 16 | 59 | M | Rectum | 4 | 1 | FOLFIRI + bevacizumab |
| 17 | 60 | M | Colon (left) | 9 | 3 | FOLFOX + cetuximab FOLFIRI + bevacizumab FOLFIRI |
Previous drug regimens are reported in chronological order of administration. All patients had histological-confirmed adenocarcinoma of the colon/rectum with metastatic liver disease not amenable to salvage surgery. In all cases, the primary tumour was KRAS (Kirsten rat sarcoma) wild-type and HER2 (human epidermal growth factor 2) positive
F Female, M Male, FOLFIRI Leucovorin + fluorouracil + irinotecan, FOLFOX Leucovorin + fluorouracil + oxaliplatin, FOLFOXIRI Leucovorin + fluorouracil + oxaliplatin + irinotecan, XELIRI Capecitabine + irinotecan, XELOX Capecitabine + oxaliplatin
Acquisition and reconstruction parameters extracted from the header DICOM of the computed tomography scans, patient by patient
| Patient | Manufacturer | Model | Slice thickness (mm) | Increment (mm) | Pixel size (mm2) | kVp | Kernel |
|---|---|---|---|---|---|---|---|
| 1 | Siemens | Sensation 64 | 3 | 3 | 0.8242 × 0.8242 | 120 | B30f |
| 2 | Siemens | Somatom Definition | 3 | 3 | 0.7031 × 0.7031 | 120 | B30f |
| 3 | Philips | Brilliance 64 | 3 | 3 | 0.8730 × 0.8730 | 100 | B |
| 4 | Siemens | Sensation 64 | 3 | 3 | 0.7812 × 0.7812 | 120 | B30f |
| 5 | Siemens | Sensation 64 | 3 | 3 | 0.8750 × 0.8750 | 120 | B30f |
| 6 | Toshiba | Aquilion | 3 | 3 | 0.7210 × 0.7210 | 120 | FC13 |
| 7 | Siemens | Sensation 64 | 3 | 3 | 0.7852 × 0.7852 | 120 | B30f |
| 8 | Siemens | Sensation 64 | 3 | 3 | 0.8047 × 0.8047 | 120 | B30f |
| 9 | Siemens | Somatom Definition | 3 | 3 | 0.7773 × 0.7773 | 100 | B30f |
| 10 | Hitachi | Eclos | 2.5 | 2.5 | 0.7100 × 0.7100 | 120 | 32 |
| 11 | Hitachi | Eclos | 2.5 | 2.5 | 0.8410 × 0.8410 | 120 | 32 |
| 12 | Siemens | Somatom Definition | 3 | 2 | 0.6875 × 0.6875 | 100 | I30f/3 |
| 13 | GE | Optima CT520 Series | 2.5 | 2.5 | 0.8477 × 0.8477 | 120 | Standard |
| 14 | GE | LightSpeed Pro 32 | 0.625 | 0.625 | 0.8926 × 0.8926 | 120 | Standard |
| 15 | Siemens | Somatom Definition | 3 | 2 | 0.6328 × 0.6328 | 100 | I30f/3 |
| 16 | Siemens | Somatom Definition | 3 | 2 | 0.7969 × 0.7969 | 100 | I30f/3 |
| 17 | Siemens | Somatom Definition | 3 | 2.5 | 0.7344 × 0.7344 | 120 | I30f/3 |
All images had a matrix size of 512 × 512 and were acquired 70–80 s after contrast injection with an automatic exposure control system
Fig. 2Correlation between Dice coefficient and average Hausdorff distance calculated for the two-dimensional (2D) and three-dimensional (3D) regions of interest (ROIs) segmented by reader 1 and reader 2. 2D ROIs, Spearman rho = -0.85 (p < 0.001); 3D ROIs, Spearman rho = -0.38 (p < 0.001)
Fig. 3Example of discrepancy between similarity indices (patient number 7): Dice coefficient was 0.86 (median two-dimensional, 0.85), whilst average Hausdorff distance was 0.48 mm (median two-dimensional, 0.21 mm). The regions of interest (blue and red lines) were approximately overlapping, but the readers differently interpreted the nature of a hypodense area adjacent to the metastasis
Correlation results (Spearman’s rho coefficients) between similarity indices (Dice coefficient and average Hausdorff distance) and size parameters of the segmented metastases for both 2D and 3D ROIs
| Correlation | 2D ROI | 3D ROI | ||
|---|---|---|---|---|
| DC | HD | DC | HD | |
| ROI manual axial diameter | 0.42 ( | -0.04 ( | 0.45 ( | 0.45 ( |
| ROI maximum 3D diameter | 0.37 ( | -0.12 ( | 0.42 ( | 0.41 ( |
| ROI volume/area | 0.30 ( | -0.17 ( | 0.36 ( | 0.30 ( |
2D Two dimensional, 3D Three dimensional, DC Dice coefficient, HD Hausdorff distance (average), ROI Region of interest
Fig. 4Means of relative changes between the RFs extracted from each lesion (n = 70) contoured by the two readers. The results from two-dimensional and three-dimensional segmentations were compared. Out of scale values have been truncated. The cluster features showed the greatest instability between readers. GLNU Grey level non-uniformity, HGLRE High grey level run emphasis, LGLRE Low grey level run emphasis, LRE Long run emphasis, LRHGLE Long run high grey level emphasis, LRLGLE Long run low grey level emphasis, RLNU Run length non-uniformity, SRE Short run emphasis, SRHGLE Short run high grey level emphasis, SRLGLE Short run low grey level emphasis
Fig. 5For all radiomic features, the intraclass correlation coefficients (ICC) of inter-reader variability are plotted and compared between three-dimensional and two-dimensional segmentations. “Excellent” ICC cutoff is shown as a red line. R1 Reader 1, R2 Reader 2, GLNU Grey level non-uniformity, HGLRE High grey level run emphasis, LGLRE Low grey level run emphasis, LRE Long run emphasis, LRHGLE Long run high grey level emphasis, LRLGLE Long run low grey level emphasis, RLNU Run length non-uniformity, SRE Short run emphasis, SRHGLE Short run high grey level emphasis, SRLGLE Short run low grey level emphasis
Mean relative changes and intraclass correlation coefficients are reported for all the textural features and both the 2D and 3D ROI sets
| 2D ROI | 3D ROI | ||||
|---|---|---|---|---|---|
| Relative change | ICC | Relative change | ICC | ||
| GLRLM | GLNU | 16% | 0.34 | 21% | 0.20 |
| HGLRE | 7% | 0.95 | 8% | 0.69 | |
| LRLGLE | |||||
| 7% | 0.93 | 9% | 0.46 | ||
| RLNU | |||||
| SRHGLE | 7% | 0.96 | 9% | 0.83 | |
| SRLGLE | 10% | 0.73 | 9% | 0.61 | |
| GLCM | AutoCorrelation | 7% | 0.70 | 7% | 0.74 |
| Cluster prominence | 418% | 0.06 | 641% | 0.08 | |
| ClusterShade | 752% | 0.13 | 1567% | 0.06 | |
| Cluster tendency | 100% | 0.20 | 116% | 0.20 | |
| Contrast | 13% | 0.95 | 22% | 0.89 | |
| Correlation | 30% | 0.49 | 57% | 0.35 | |
| Energy | 23% | 0.77 | 25% | 0.64 | |
| Entropy | 10% | 0.76 | 11% | 0.66 | |
| InformationMeasureCorrel1 | 65% | 0.62 | 136% | 0.48 | |
| InformationMeasureCorrel2 | 22% | 0.49 | 46% | 0.35 | |
| InverseDifferMomentNormal | 0% | 0.95 | 0% | 0.89 | |
| InverseVariance | 1% | 0.96 | 2% | 0.88 | |
| MaxProbability | 19% | 0.82 | 21% | 0.74 | |
| SumAverage | 3% | 0.73 | 3% | 0.76 | |
| SumEntropy | 12% | 0.45 | 14% | 0.34 | |
| SumVariance | 6% | 0.80 | 6% | 0.84 | |
Bold text is used for features found robust against inter-reader variability (ICC > 0.90 and mean relative change < 10%)
2D Two dimensional, 3D Three dimensional, GLCM Grey level co-occurrence matrix, GLNU Grey level non-uniformity, GLRLM Grey level run length matrix, HGLRE High grey level run emphasis, ICC Intraclass correlation coefficient, LGLRE Low grey level run emphasis, LRE Long run emphasis, LRHGLE Long run high grey level emphasis, LRLGLE Long run low grey level emphasis, RLNU Run length non-uniformity, SRE Short run emphasis, SRHGLE Short run high grey level emphasis, SRLGLE Short run low grey level emphasis.
Comparison of the radiomic features obtained using manual 2D ROIs by R1 versus R2 and, for R1, using manual versus circular 2D ROIs
For the main lesion of each patient, the RFs from R1 2D ROIs were compared to R2 2D ROIs and to the circular 2D ROIs (extROIs and intROIs). Mean relative discrepancy taking R1 values as reference is reported. Inter-reader variability was preponderant for nearly all RFs. As expected, RFs from extROIs and intROIs had a divergent behaviour in respect of R1 2D ROIs, whose characteristics were intermediate. The colour code refers to the absolute value of discrepancy
2D Two-dimensional, extROI Smallest circular segmentation including the whole lesion, GLCM Grey level co-occurrence matrix, GLNU Grey level non-uniformity, GLRLM Grey level run length matrix, HGLRE High grey level run emphasis, intROI Largest circular segmentation completely inside the lesion, LGLRE Low grey level run emphasis, LRE Long run emphasis, LRHGLE Long run high grey level emphasis, LRLGLE Long run low grey level emphasis, R1 Reader 1, R2 Reader 2, RFs Radiomic features, RLNU Run length non-uniformity, ROIs Region of interest, SRE Short run emphasis, SRHGLE Short run high grey level emphasis, SRLGLE Short run low grey level emphasis